CD44 and prostate carcinoma: This soluble CD44 can bind to the vimentin head domain on the surface of endothelial cells, which is consistent with the fact that both CD44 and vimentin are overexpressed in oral squamous cell carcinoma (OSCC) and prostate cancer; however, the molecular basis of this association has not been fully elucidated [35].